The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia.

Sigit Riyarto, Budi Hidayat, Benjamin Johns, Ari Probandari, Yodi Mahendradhata, Adi Utarini, Laksono Trisnantoro, Sabine Flessenkaemper

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


This paper assesses the extent of the financial burden due to out-of-pocket payments for health care incurred by people living with HIV (PLHIV) and the effect of this burden on their financial capacity. Data were collected in a cross-sectional survey of 353 PLHIV from three cities in Indonesia (Jakarta, Jogjakarta and Merauke). Respondents in Jakarta were sampled from one hospital and one non-governmental organization working with PLHIV. In Jogjakarta and Merauke, all HIV patients on antiretroviral therapy (ART) who came to selected hospitals during the interview period were asked to participate in the survey. The survey collected data on the frequency and extent of payments for HIV-related care, with answers cross-checked against medical records. Results show that PLHIV had different burdens of payments in the different geographical areas. On average, respondents in Jogjakarta spent 68%, and PLHIV on ART in Jakarta spent 96%, of monthly expenditure for HIV-related care, indicating a substantial financial burden for many ART patients. These patients depended on several sources of finance to cover the costs of their care, with donations from their immediate family being the most common method, selling assets and payments from personal income being the second most common method in Jakarta and Jogjakarta, respectively. Most PLHIV in these two areas did not have insurance. In Merauke, there were little observed out-of-pocket payments because the government covers medical costs via the local budget and health insurance for the poor. The results of this study confirm previous findings that providing subsidized ART drugs alone does not ensure financial accessibility to HIV care. Thus, the government of Indonesia at central and local levels should consider covering HIV care additional to providing antiretroviral drugs free of charge. Social health insurance should also be encouraged.

Original languageEnglish
Pages (from-to)272-282
Number of pages11
JournalHealth policy and planning
Issue number4
Publication statusPublished - Jul 2010


Dive into the research topics of 'The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia.'. Together they form a unique fingerprint.

Cite this